Chunqing Wang

Dr. Chunqing Wang

University of New Mexico, Albuquerque, New Mexico, USA
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2020 in Science
Verified
Journal Article
Closed access
PDF file
ZZZhangsen Zhou
Zhangsen Zhou
MTMauricio Torres
Mauricio Torres
HSHaibo Sha
Haibo Sha
CHChristopher J. Halbrook
Christopher J. Halbrook
FBFrançoise Van Den Bergh
Françoise Van Den Bergh
LQLing Qi
Ling Qi
The endoplasmic reticulum (ER) engages mitochondria at specialized ER domains known as mitochondria-associated membranes (MAMs). Here, we used three-dimensional high-resolution imaging to investigate the formation of pleomorphic “megamitochondria” with altered MAMs in brown adipocytes lacking the Sel1L-Hrd1 protein complex of ER-associated protein degradation (ERAD). Mice with ERAD deficiency in brown adipocytes were cold sensitive and exhibited mitochondrial dysfunction. ERAD deficiency affected ER-mitochondria contacts and mitochondrial dynamics, at least in part, by regulating the turnover of the MAM protein, sigma receptor 1 (SigmaR1). Thus, our study provides molecular insights into ER-mitochondrial cross-talk and expands our understanding of the physiological importance of Sel1L-Hrd1 ERAD.

26 October 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LWLu Wang
Lu Wang
YLYan Luo
Yan Luo
LLLiping Luo
Liping Luo
DWDandan Wu
Dandan Wu
XDXiaofeng Ding
Xiaofeng Ding
Meilian LiuMeilian Liu
Meilian Liu
ILC2s are present in adipose tissue and play a critical role in regulating adipose thermogenesis. However, the mechanisms underlying the activation of adipose-resident ILC2s remain poorly defined. Here, we show that IL-33, a potent ILC2 activator, stimulates phosphorylation of AMPK at Thr172 via TAK1 in primary ILC2s, which provides a feedback mechanism to inhibit IL-33–induced NF-κB activation and IL-13 production. Treating ILC2s with adiponectin or an adiponectin receptor agonist (AdipoRon) activated AMPK and decreased IL-33–NF-κB signaling. AdipoRon also suppressed cold-induced thermogenic gene expression and energy expenditure in vivo. In contrast, adiponectin deficiency increased the ILC2 fraction and activation, leading to up-regulated thermogenic gene expression in adipose tissue of cold-exposed mice. ILC2 deficiency or blocking ILC2 function by neutralization of the IL-33 receptor with anti-ST2 diminished the suppressive effect of adiponectin on cold-induced adipose thermogenesis and energy expenditure. Taken together, our study reveals that adiponectin is a negative regulator of ILC2 function in adipose tissue via AMPK-mediated negative regulation of IL-33 signaling.

1 September 2018 in Cell Reports
Verified
Journal Article
Open access
XZXing Zhang
Xing Zhang
YLYan Luo
Yan Luo
CWChunqing Wang
Chunqing Wang
XDXiaofeng Ding
Xiaofeng Ding
XYXin Yang
Xin Yang
Meilian LiuMeilian Liu
Meilian Liu
Beige adipocytes are present in white adipose tissue (WAT) and have thermogenic capacity to orchestrate substantial energy metabolism and counteract obesity. However, adipocyte-derived signals that act on progenitor cells to control beige adipogenesis remain poorly defined. Here, we show that adipose-specific depletion of Raptor, a key component of mTORC1, promoted beige adipogenesis through prostaglandins (PGs) synthesized by cyclooxygenase-2 (COX-2). Moreover, Raptor-deficient mice were resistant to diet-induced obesity and COX-2 downregulation. Mechanistically, mTORC1 suppressed COX-2 by phosphorylation of CREB-regulated transcription coactivator 2 (CRTC2) and subsequent dissociation of CREB to cox-2 promoter in adipocytes. PG treatment stimulated PKA and promoted differentiation of progenitor cells to beige adipocytes in culture. Ultimately, we show that pharmacological inhibition or suppression of COX-2 attenuated mTORC1 inhibition-induced thermogenic gene expression in inguinal WAT in vivo and in vitro. Our study identifies adipocyte-derived PGs as key regulators of white adipocyte browning, which occurs through mTORC1 and CRTC2.

18 December 2019 in Autophagy
Verified
Journal Article
Closed access
XZXing Zhang
Xing Zhang
DWDandan Wu
Dandan Wu
CWChunqing Wang
Chunqing Wang
YLYan Luo
Yan Luo
XDXiaofeng Ding
Xiaofeng Ding
Meilian LiuMeilian Liu
Meilian Liu
Dysregulation of macroautophagy/autophagy is implicated in obesity and insulin resistance. However, it remains poorly defined how autophagy regulates adipocyte development. Using adipose-specific r...

8 January 2024 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
XZXing Zhang
Xing Zhang
XDXiaofeng Ding
Xiaofeng Ding
CWChunqing Wang
Chunqing Wang
QLQue Le
Que Le
DWDandan Wu
Dandan Wu
Meilian LiuMeilian Liu
Meilian Liu

1 January 2016 in Journal of Cancer
Verified
Journal Article
Open access
JZJi Zhou
Ji Zhou
HDHuaxin Duan
Huaxin Duan
YXYu Xie
Yu Xie
YNYichong Ning
Yichong Ning
XZXing Zhang
Xing Zhang
JZJianlin Zhou
Jianlin Zhou
Transcription factor AP-2 alpha (AP-2α or TFAP2A) is a newly identified prognostic marker of chemotherapy; its expression is positively correlated with chemosensitivity and survival of cancer patients. Using computational programs, we predicted that the coding region of AP-2α gene contains a potential miRNA response element (MRE) of miR-193a-5p, and the single nucleotide polymorphism (SNP) site (c.497A>G, rs111681798) resides within the predicted MRE. The results of luciferase assays and Western blot analysis demonstrated that miR-193a-5p negatively regulated the expression of AP-2α proteins, but have no influence on the mutant AP-2α (c.497A>G). Infection with lentiviral AP-2α gene or miR-193a-5p inhibitor in the bladder cancer cells decreased migration and cisplatin resistance, while knockdown of AP-2α gene or overexpression of miR-193a-5p in the urothelial cell line SV-HUC-1 increased migration and cisplatin resistances. We concluded that miR-193a-5p induced cisplatin resistance by repressing AP-2α expression in bladder cancer cells.